What is the recommended treatment for a patient with a left nostril nose culture showing 33% polymorphonuclear (PMN) cells and 67% mononuclear cells?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nasal Culture with 33% PMN and 67% Mononuclear Cells: Clinical Interpretation and Management

A nasal culture showing 33% polymorphonuclear cells and 67% mononuclear cells from the left nostril does not indicate bacterial sinusitis requiring antibiotic treatment and should be managed with symptomatic care only. 1, 2

Understanding the Clinical Context

The cellular composition you describe suggests a predominantly non-bacterial inflammatory process. Here's why this matters:

  • **Nasal cytology with <50% neutrophils (PMNs) argues against acute bacterial infection**, as bacterial sinusitis typically shows marked neutrophilic predominance (>80% PMNs) 3
  • The 67% mononuclear cell predominance suggests viral rhinitis, allergic inflammation, or chronic non-bacterial inflammation rather than acute bacterial infection 3, 2
  • Nasal cytology has limited specificity (40-90%) and sensitivity (67-80%) for bacterial sinusitis, particularly because viral infections can also cause some neutrophilia 3

When Bacterial Sinusitis is Actually Present

To justify antibiotic treatment, patients must meet specific clinical criteria, not just culture results 1, 4:

  • Persistent symptoms ≥10 days without improvement 1, 4
  • Severe symptoms: fever ≥39°C (102°F) with purulent nasal discharge for ≥3-4 consecutive days 1, 4
  • Worsening symptoms after initial improvement (double-worsening) 1, 4

The cellular composition alone does not establish the diagnosis of bacterial sinusitis. 3, 1

Recommended Management Approach

First-Line Treatment (Symptomatic Care)

For symptoms <7-10 days or mild-to-moderate severity, observation with symptomatic treatment is preferred over antibiotics 1, 2:

  • Saline nasal irrigation (2-3 times daily) to enhance mucociliary clearance and improve drainage 1, 2
  • Analgesics/antipyretics (acetaminophen or ibuprofen) for pain or fever 2
  • Adequate hydration to thin secretions 2
  • Topical intranasal corticosteroids may provide modest symptom relief 2

When to Consider Antibiotics

Only if clinical criteria for bacterial sinusitis are met (see above), then 1, 4, 5:

  • First-line: Amoxicillin (narrow-spectrum targeting Streptococcus pneumoniae and Haemophilus influenzae) 1, 5, 6
  • Alternative: High-dose amoxicillin-clavulanate (875 mg twice daily or 2g three times daily) if risk factors for resistance present (recent antibiotic use, daycare contact) 1, 4, 5
  • Duration: 10-14 days 4

For Penicillin-Allergic Patients

  • Non-severe allergy: Second or third-generation cephalosporins (cefuroxime, cefpodoxime) 4
  • Severe allergy: Respiratory fluoroquinolones (levofloxacin, moxifloxacin) 4, 5

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics based on nasal culture results alone without meeting clinical diagnostic criteria for bacterial sinusitis 1, 7
  • Avoid topical decongestants beyond 3-5 days due to risk of rhinitis medicamentosa (rebound congestion) 1, 2
  • Do not use oral antihistamines in non-allergic rhinosinusitis, as anticholinergic effects worsen nasal dryness 1
  • Recognize that 60% of presumed bacterial sinusitis resolves spontaneously without antibiotics 1
  • Surveillance nasal cultures are of questionable value and should not drive treatment decisions 3

Special Considerations

If eosinophils are present (>10% on nasal cytology), this suggests underlying allergic rhinitis or eosinophilic non-allergic rhinitis, which may benefit from intranasal corticosteroids long-term 3, 1

The presence of S. pneumoniae, H. influenzae, or M. catarrhalis in nasopharyngeal cultures may have pathogenic significance if symptoms persist beyond 7 days, but treatment should still be based on clinical criteria, not culture alone 8, 9, 7

References

Guideline

Rhinosinusitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento para Rinofaringitis Aguda

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Facial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005

Research

Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001

Research

Microbiology of sinusitis.

Proceedings of the American Thoracic Society, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.